CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial (Q44471772)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial (English)

1 reference

Europe PubMed Central

3 December 2017

anti-retroviral agent

0 references

0 references

2

object named as

Raoul Moh

1 reference

Europe PubMed Central

3 December 2017

Delphine Gabillard

8

object named as

Delphine Gabillard

1 reference

Europe PubMed Central

3 December 2017

Xavier Anglaret

17

object named as

Xavier Anglaret

1 reference

Europe PubMed Central

3 December 2017

Christine Danel

1

object named as

Christine Danel

1 reference

Europe PubMed Central

3 December 2017

author name string

Albert Minga

3

1 reference

Europe PubMed Central

3 December 2017

Amani Anzian

4

1 reference

Europe PubMed Central

3 December 2017

Olivier Ba-Gomis

5

1 reference

Europe PubMed Central

3 December 2017

Constance Kanga

6

1 reference

Europe PubMed Central

3 December 2017

Gustave Nzunetu

7

1 reference

Europe PubMed Central

3 December 2017

François Rouet

9

1 reference

Europe PubMed Central

3 December 2017

Souleymane Sorho

10

1 reference

Europe PubMed Central

3 December 2017

Marie-Laure Chaix

11

1 reference

Europe PubMed Central

3 December 2017

Serge Eholié

12

1 reference

Europe PubMed Central

3 December 2017

Hervé Menan

13

1 reference

Europe PubMed Central

3 December 2017

Delphine Sauvageot

14

1 reference

Europe PubMed Central

3 December 2017

Emmanuel Bissagnene

15

1 reference

Europe PubMed Central

3 December 2017

Roger Salamon

16

1 reference

Europe PubMed Central

3 December 2017

Trivacan ANRS 1269 trial group

18

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

3 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

3 December 2017

367

1 reference

Europe PubMed Central

3 December 2017

9527

1 reference

Europe PubMed Central

3 December 2017

1981-1989

1 reference

Europe PubMed Central

3 December 2017

Structured treatment interruptions for the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV RNA in plasma rebounds within days during structured treatment interruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Structured Treatment Interruption: Approaches and Risks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 subtyping using phylogenetic analysis of pol gene sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged Treatment Interruption after Immunologic Response to Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968887-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)68887-9

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44471772&oldid=2025181727"